A randomized double blind study of the effect of finasteride on hair growth in male patients of androgenetic alopecia
Eighty male patients with AGA, not treated in the previous 6 months were enrolled in this randomized, double blind, placebo controlled trial to assess the safety and efficacy of finasteride, 1mg daily, on hair growth. Patients were randomized into 2 groups: Group 1 received 1 mg of finasteride daily...
Saved in:
Main Authors: | Prasad H (Author), Khanna Neena (Author), Pandhi R (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2005-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Male Androgenetic Alopecia : Response To Finasteride
by: Thakkar Suruchi, et al.
Published: (2004) -
Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review
by: Almuntaserbellah Almudaimeegh, et al.
Published: (2024) -
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis
by: Solam Lee, et al.
Published: (2018) -
Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach
by: Ahmed OAA, et al.
Published: (2018) -
Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial
by: DuBois J, et al.
Published: (2021)